[lu-177]-pnt2002,abiraterone,enzalutamide
pfizer,astellas,point biopharma,janssen
['splash', 'crpc', '$pnt']
$pnt new article : point biopharma provides updated efficacy and safety data from the lead-in cohort of the phase 3 splash trial in mcrpc at esmo congress 2022 get all the latest $pnt related news here : 
We’ll make staying up-to-date on top of your investments easy for you. Create a free account and get real-time financial news updates for your portfolio!